Takeda Pharmaceutical Company Limited (Ticker: TAK) is a leading global biopharmaceutical firm headquartered in Tokyo, Japan, specializing in the research, development, manufacturing, and marketing of innovative pharmaceuticals and healthcare products. With a strong focus on areas such as oncology, gastroenterology, and neuroscience, Takeda leverages its advanced scientific capabilities to drive growth and deliver transformative therapies that address unmet medical needs. The company is committed to sustainability and improving patient outcomes globally while maintaining a robust pipeline of products, positioning itself as a key player in the dynamic pharmaceutical landscape.